Randomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocol

@inproceedings{Harding2015RandomisedTO,
  title={Randomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocol},
  author={Jane E Harding and Joanne Elizabeth Hegarty and Caroline A Crowther and Richard P Edlin and Greg D Gamble and Jane Marie Alsweiler},
  booktitle={BMC pediatrics},
  year={2015}
}
BACKGROUND Neonatal hypoglycaemia is common, affecting up to 15% of newborn babies and 50% of those with risk factors (preterm, infant of a diabetic, high or low birthweight). Hypoglycaemia can cause brain damage and death, and babies born at risk have an increased risk of developmental delay in later life. Treatment of hypoglycaemia usually involves additional feeding, often with infant formula, and admission to Neonatal Intensive Care for intravenous dextrose. This can be costly and inhibit… CONTINUE READING
4 Citations
24 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 24 references

ANZNN DATA DICTIONARY: Australia: National Perinatal Epidemiology and Statistics Unit (NPESU); 2014; p

  • Australian, New Zealand Neonatal Network
  • 90. Submit your next manuscript to BioMed Central…
  • 2015
2 Excerpts

Similar Papers

Loading similar papers…